Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Meningococcal ACWY Vaccines”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00126945
What this trial is testing

Evaluate 4 Different Formulations of Meningococcal Serogroups A,C,W-135,Y Conjugate Vaccine When Given as 1 Dose to Healthy Subjects Aged 15-19 Yrs

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 125
Testing effectiveness (Phase 2)Study completedNCT00310817
What this trial is testing

Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Children Aged 12-59 Months.

Who this might be right for
Meningococcal Meningitis
Novartis Vaccines 623
Large-scale testing (Phase 3)Study completedNCT01192997
What this trial is testing

Comparison of Two Meningococcal ACWY Conjugate Vaccines

Who this might be right for
Meningococcal Meningitis
Public Health England 91
Large-scale testing (Phase 3)Study completedNCT01682876
What this trial is testing

Immunogenicity, Safety and 1 Year Persistence of Antibodies After Either One or Two Doses of Meningococcal ACWY Conjugate Vaccine in Healthy Children 2 Through 10 Years of Age.

Who this might be right for
Meningococcal DiseaseInfections, Meningococcal
GlaxoSmithKline 715
Not applicableStudy completedNCT02811120
What this trial is testing

PRIME Follow up - Quadri Meningo Vacinees

Who this might be right for
Meningococcal Disease
Public Health England 57
Testing effectiveness (Phase 2)Study completedNCT01994629
What this trial is testing

Safety and Immunogenicity of One Dose of Novartis' Meningococcal ACWY-CRM Vaccine and GlaxoSmithKline Biologicals' Meningococcal ACWY-TT Vaccine in Healthy Toddlers

Who this might be right for
Meningococcal Disease
Novartis Vaccines 202
Testing effectiveness (Phase 2)Study completedNCT03652610
What this trial is testing

Investigate the Safety and Immunogenicity of Different Formulations of GSK Biologicals' Meningococcal ACWY Conjugate Vaccine (GSK3536820A and Menveo) Administered to Healthy Adults 18 to 40 Years of Age

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 996
Testing effectiveness (Phase 2)Study completedNCT00488683
What this trial is testing

B Cell Response to a Primary and a Booster Course of the Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Infants

Who this might be right for
Meningococcal Disease
Novartis Vaccines 216
Large-scale testing (Phase 3)Study completedNCT00474526
What this trial is testing

Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants

Who this might be right for
Meningitis, Meningococcal
Novartis Vaccines 4,545
Large-scale testing (Phase 3)Study completedNCT01547715
What this trial is testing

Immunogenicity and Safety of Meningococcal ACWY Conjugate Vaccine in Healthy Subjects From 2 to 75 Years of Age in India

Who this might be right for
Bacterial Meningitis
Novartis 180
Testing effectiveness (Phase 2)Study completedNCT00427908
What this trial is testing

Study in Children to Evaluate Non-Inferiority and Persistence up to 5 Years of GSK Bio Meningococcal Vaccine 134612

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 613
Testing effectiveness (Phase 2)Study completedNCT00262028
What this trial is testing

Study of the Safety and Immune Response of a Meningococcal Vaccine Administered to Healthy Children

Who this might be right for
Prevention of Meningococcal Disease
Novartis Vaccines 910
Post-approval studies (Phase 4)UnknownNCT03682939
What this trial is testing

Evaluation of Safety and Immunogenicity of Meningococcal B and Meningococcal ACWY Vaccine in at Risk Population

Who this might be right for
HivMeningitis, MeningococcalHIV Infections
St George's, University of London 55
Not applicableStudy completedNCT07824076
What this trial is testing

Impact of an e-Bug Educational Intervention on HPV and Meningococcal ACWY Vaccine Uptake in Middle School Students

Who this might be right for
Meningococcal ACWY VaccinesHPV CoverageMeningitidis Infections+1 more
Centre Hospitalier Universitaire de Nice 53,608
Large-scale testing (Phase 3)Study completedNCT03263403
What this trial is testing

Non Inferiority Trial of Locally Manufactured Meningococcal ACWY Vaccine 'Ingovax ACWY' in Bangladesh.

Who this might be right for
Meningococcal Vaccine
International Centre for Diarrhoeal Disease Research, Bangladesh 88
Post-approval studies (Phase 4)Study completedNCT00227422
What this trial is testing

Assess the Non-inferiority of GSK Biologicals' Mencevax™ ACWY (Manufactured by a New Process) vs Mencevax™ ACWY (the Already Existing Vaccine in the Market) When Given as a Single Dose to Subjects Aged 2-30 Yrs

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 324
Testing effectiveness (Phase 2)Study completedNCT00126984
What this trial is testing

Study in Children to Evaluate the Immunogenicity and Safety of 4 Formulations of GSK Bio MenACWY-TT Conjugate Vaccine

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 508
Not applicableStudy completedNCT01452438
What this trial is testing

Safety Surveillance of MenACWY-CRM Vaccine in Children

Who this might be right for
Meningococcal Disease
Novartis Vaccines 393
Large-scale testing (Phase 3)Study completedNCT01934140
What this trial is testing

Study to Evaluate the Long-term Antibody Persistence of GlaxoSmithKline (GSK) Biologicals' MenACWY-TT Vaccine (GSK134612) Versus Mencevax ACWY in Healthy Adolescents and Adults and Booster Response to MenACWY-TT Vaccine Administered at 10 Years Post-primary Vaccination

Who this might be right for
Infections, Meningococcal
Pfizer 311
Post-approval studies (Phase 4)Study completedNCT01593514
What this trial is testing

Understanding the Immune Response to Two Different Meningitis Vaccines

Who this might be right for
MeningitisMeningococcal DiseaseSepticaemia
University of Oxford 20
Next Page